Business · 15/07/2020Updated: 10/17/2026 · 1 min read
FDA Adds Two Tropical Diseases to List Eligible for Priority Review Vouchers
Summary
The FDA is expanding its list of tropical diseases to include opisthorchiasis and paragonimiasis, making sponsors of drug or biological product applications for these diseases eligible for priority review vouchers.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →